1-4 of 4
Karl-Heinz Thierauch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4509: BAY 87-2243 targets hypoxia-induced activation and stabilization of HIF-1α: A novel approach to overcome resistance mechanisms in cancer therapy

Kerstin Berhoerster, Michael Haerter, Peter Ellinghaus, Iring Heisler, Hartmut Beck, Susanne Greschat, Karl-Heinz Thierauch, Scott Wilhelm, Oliver von Ahsen, Holger Hess-Stumpp, Karl Ziegelbauer
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4509.
https://doi.org/10.1158/1538-7445.AM2011-4509
Published: 15 April 2011
View article titled, Abstract 4509: BAY 87-2243 targets hypoxia-induced activation and stabilization of HIF-1α: A novel approach to overcome resistance mechanisms in cancer therapy
Journal Articles

Abstract 1666: Regorafenib (BAY 73-4506): preclinical pharmacology and clinical identification and quantification of its major metabolites

Dieter Zopf, Roland Heinig, Karl-Heinz Thierauch, Claudia Hirth-Dietrich, Frank-Thorsten Hafner, Olaf Christensen, Tiffany Lin, Scott Wilhelm, Martin Radtke
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1666.
https://doi.org/10.1158/1538-7445.AM10-1666
Published: 15 April 2010
View article titled, Abstract 1666: Regorafenib (BAY 73-4506): preclinical pharmacology and clinical identification and quantification of its major metabolites
Journal Articles

ZK 261991. a novel VEGFR inhibitor for tumor therapy

Karl-Heinz Thierauch, Martin Haberey, Holger Hess-Stumpp, Andreas Huth, Stuart Ince, Martin Krueger, Rolf Bohlmann, Ludwig Zorn, Ulla Moenning, Kirstin Meyer, Andreas Reichel
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2135.
Published: 01 May 2007
View article titled, ZK 261991. a novel VEGFR inhibitor for tumor therapy
Journal Articles

PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration

Jeanette M. Wood, Guido Bold, Elizabeth Buchdunger, Robert Cozens, Stefano Ferrari, Jörg Frei, Francesco Hofmann, Jürgen Mestan, Helmut Mett, Terence O’Reilly, Elke Persohn, Johannes Rösel, Christian Schnell, David Stover, Andreas Theuer, Harry Towbin, Fritz Wenger, Kathie Woods-Cook, Andreas Menrad, Gerhard Siemeister, Michael Schirner, Karl-Heinz Thierauch, Martin R. Schneider, Joachim Drevs, Georg Martiny-Baron, Frank Totzke, Dieter Marmé
Journal: Cancer Research
Cancer Res (2000) 60 (8): 2178–2189.
Published: 01 April 2000
View article titled, PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration
Open the PDF for PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration in another window